.OHSU Knight Cancer Institute is hiring a #sarcoma med onc (Asst Prof) to join our thriving and expanding team. #OHSUsarcoma is collaborative & engaged group dedicated to sarcoma patients and research - and we're FUN! DM me or apply here: bit.ly/3TMsMUe

Congratulations to our fellow @RajatThawani for being awarded the Medical Research Foundation Early Career Investigator Grant, with mentorship from the Davare Lab. He will work on strategies to bypass intrinsic resistance in ROS1 rearranged NSCLC. The ROS1ders, Inc. #LCSM

Mr T continues to raise awareness for #lungcancer, but this year from heaven. #cancer may steal from us the people (+#dogs + #cats) we love. But as Mr T’s sign says, we have to keep fighting the fight + helping each other. Pls like + RT if you agree. #LCAM #StrongerTogether

Our recent collaboration with Dr. Angela Waanders Lurie Children's, Adam Resnick, Payal Jain, PhD reveals actionable ROS1 alterations in rare pediatric cancer. NGS should be every cancer patients healthcare right! CSH Molecular Case Studies molecularcasestudies.cshlp.org/content/8/6.co…

Going to my first IASLC #TTLC23 and presenting our abstract from the Davare Lab Also received an educational grant for the abstract! A great break from the PNW winters! OHSU HemeOnc Fellowship Hem-Onc Fellows Network

Is there more to ROS1 in cancer than the ROS1 fusions? Targetable by ROS1 TKI? Yes, maybe. See our pre-print. #ROS1

Representing OHSU Knight Cancer Institute at #TTLC23 in Santa Monica! Dr Cetnar was a panelist on the mesothelioma and thymic malignancies session. Rajat Thawani presented his research from the Davare Lab

Women who never smoked have twice the risk of developing #lungcancer as men. A study in Sept 2020 in Lung Cancer Management showed that ~ half of women dx w lung cancer globally never smoked vs ~ 15-20% of men. Ladies, pls watch out for symptoms. 💔 #lcsm everydayhealth.com/cancer/lung-ca…

Help support the Pediatric Brain Tumor Program at OHSU Doernbecher Children's Hospital and sport a cool T-Shirt while doing it! pbtp.webstarts.com #pediatric_cancer #braincancer OHSU Doernbecher Children's Hospital

I remember interviewing for a faculty position once, being co-first author with a man on a publication, and being asked if I really contributed equally to the work. This confirms what we women have known for a long time.

Certain oncogene drivers have a higher affinity for brain metastases. Should our screening guidelines change? Editor - Neuro-Oncology Advances SNO Randy D'Amico, MD #brainmetastases #NSCLC Northwell Health Lenox Hill Neurosurgery Brain metastasis screening in the molecular age academic.oup.com/noa/article/5/…

In press! Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors | EMBO Molecular Medicine embopress.org/doi/full/10.15… #ROS1 EMBO Mol. Medicine

PDX vs. original tumor in childhood cancer👇

Read out manuscript "TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers" in npj Journals This collaborative work from Davare Lab Alexander Drilon MD shows data on the use of type II TKIs in ROS1 fusion cancers with L2086F mutation nature.com/articles/s4169…

“This effort fills a critical gap in pediatric oncology and will accelerate effective treatments for youth impacted by these devastating bone cancers.” - Kuni Foundation president Angela Hult: bit.ly/3AAHSYw

“When I met Dr. Cetnar, he had an associate who was doing research with ROS1. They told me my diagnosis, explained everything about it, and gave me so much relief and hope I said, ‘Can I hug both of you? You both gave me my life back.’" Clare's story: bit.ly/4fVcP8J

Most negative results remain unpublished, creating blind spots in AI training and risking suggestions of already-failed ideas. AI can transform science—but only if it sees the full record of scientific successes and failures. nature.com/articles/d4158… #AI #OpenScience #scicomm